Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Genotype 4 Infection”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01725542
What this trial is testing

Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders

Who this might be right for
HCV-HIV Co-Infection
ANRS, Emerging Infectious Diseases 75
Testing effectiveness (Phase 2)Study completedNCT01858766
What this trial is testing

Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 379
Testing effectiveness (Phase 2)Study completedNCT03036839
What this trial is testing

Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 95
Large-scale testing (Phase 3)UnknownNCT01653236
What this trial is testing

Boceprevir With Peginterferon Alfa-2b and Ribavirin in the Treatment-naive Patients Infected With Genotype 4 Chronic Hepatitis C Infection

Who this might be right for
Genotype 4 Chronic Hepatitis C Infection
Theodor Bilharz Research Institute 40
Large-scale testing (Phase 3)Study completedNCT02073656
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

Who this might be right for
Hepatitis C VirusHIV
Gilead Sciences 335
Large-scale testing (Phase 3)Study completedNCT02487199
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 18
Post-approval studies (Phase 4)Study completedNCT00502099
What this trial is testing

Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4

Who this might be right for
Hepatitis C
Amr Hafez 217
Large-scale testing (Phase 3)Ended earlyNCT02504099
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 3
Testing effectiveness (Phase 2)Study completedNCT04385407
What this trial is testing

Sofosbuvir With Ribavirin or Simeprevir With HCV GT4 Egyptian Patients

Who this might be right for
Chronic Hepatitis C Virus Infection
Beni-Suef University 203
Large-scale testing (Phase 3)UnknownNCT01655966
What this trial is testing

Vitamin D as an add-on Therapy With Pegylated Interferon and Ribavirin for Chronic Hepatitis c

Who this might be right for
Chronic Hepatitis c
Cairo University 80
Testing effectiveness (Phase 2)Study completedNCT02350569
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 17
Large-scale testing (Phase 3)WithdrawnNCT02099604
What this trial is testing

Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases
Testing effectiveness (Phase 2)Study completedNCT02107365
What this trial is testing

Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)

Who this might be right for
Hepatitis C Virus Genotype 4 Infection
ANRS, Emerging Infectious Diseases 60
Large-scale testing (Phase 3)Study completedNCT02243293
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C Virus
AbbVie 694
Post-approval studies (Phase 4)UnknownNCT02950870
What this trial is testing

Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.

Who this might be right for
Chronic Hepatitis, C Virus
University of Modena and Reggio Emilia 75
Testing effectiveness (Phase 2)Study completedNCT02765490
What this trial is testing

Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Janssen Research & Development, LLC 365
Post-approval studies (Phase 4)Study completedNCT00540345
What this trial is testing

Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 300
Large-scale testing (Phase 3)Study completedNCT01399619
What this trial is testing

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 310
Not applicableUnknownNCT03510637
What this trial is testing

"Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt

Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases 7,500
Post-approval studies (Phase 4)Ended earlyNCT02940691
What this trial is testing

Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs

Who this might be right for
Hepatitis C
Kirby Institute 32
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation